← Joaquin Duato

What podcasts say about Joaquin Duato

Every statement, with the speaker, the exact quote and the moment it was said.

What Joaquin Duato has said on podcasts

8 statements · 8 positive

  1. on AI-augmented biomedical researchPositiveSep 26, 2025· Mad Money w/ Jim Cramer

    Duato predicts biology, chemistry, and AI will produce cures for many incurable diseases.

    “the combination of our advances in biology and chemistry amplified by artificial intelligence are going to give us cures for many diseases that we thought were incurable.”

    Listen at 29:39

    Open the episode · Mad Money w/ Jim Cramer 9/26/25
  2. on CarvyktiPositiveSep 26, 2025· Mad Money w/ Jim Cramer

    Duato says Carvykti patients were disease-free five years after one treatment.

    “patients that were about to go into hospice are disease-free five years after a single administration, Jim.”

    Listen at 30:05

    Open the episode · Mad Money w/ Jim Cramer 9/26/25
  3. on InlexoPositiveSep 26, 2025· Mad Money w/ Jim Cramer

    Duato says Inlexo can enable bladder-cancer patients to retain their bladder.

    “what is going to make possible is that patients keep their bladder.”

    Listen at 31:13

    Open the episode · Mad Money w/ Jim Cramer 9/26/25
  4. on Abiomed heart pumpsPositiveSep 26, 2025· Mad Money w/ Jim Cramer

    Duato says Abiomed heart-pump patients lived 600 additional days over ten years.

    “they were living over a 10-year period 600 days more.”

    Listen at 32:17

    Open the episode · Mad Money w/ Jim Cramer 9/26/25
  5. Duato predicts Johnson & Johnson will remain a healthcare-innovation leader.

    “we will remain the leaders as we are today, the undisputed leaders in healthcare innovation.”

    Listen at 33:30

    Open the episode · Mad Money w/ Jim Cramer 9/26/25
  6. on Johnson & Johnson talc litigationPositiveSep 26, 2025· Mad Money w/ Jim Cramer

    Duato expects the Daubert hearing to benefit Johnson & Johnson.

    “we think that's going to be positive for us.”

    Listen at 34:20

    Open the episode · Mad Money w/ Jim Cramer 9/26/25
  7. on Johnson & Johnson ovarian-cancer litigationPositiveSep 26, 2025· Mad Money w/ Jim Cramer

    Duato says Johnson & Johnson won 16 of 17 ovarian-cancer cases over eleven years.

    “we have won 16 out of 17 cases in the last 11 years.”

    Listen at 34:34

    Open the episode · Mad Money w/ Jim Cramer 9/26/25
  8. Johnson & Johnson expects 2026 to outperform 2025 and 2027 to outperform 2026.

    “we believe that 26 is going to be better than 25 and 27 better than 26.”

    Listen at 35:49

    Open the episode · Mad Money w/ Jim Cramer 9/26/25

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.